
|Videos|April 8, 2022
Residual Cardiovascular Risk
Ian Riddock, MD, describes residual cardiovascular risk, both with and without the use of statin therapies.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT
2
5 Ways ACOs Can Improve Care, Achieve Meaningful Savings
3
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
4
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
5















































